Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-05-18

Clinical Trial Update: Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases [NA]

View source ↗

Summary

The clinical trial evaluating levetiracetam for seizures caused by brain metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors, Seizure | NA | Status: WITHDRAWN